天美传媒

Warren Center for Neuroscience Drug Discovery lead researchers discover a therapy that may treat memory loss and slow the progression of Alzheimer鈥檚 disease. Read More

Vanderbilt research describes a new investigational peptide drug that can penetrate immune and nonimmune cells, and block inflammatory signaling in a preclinical model of atopic dermatitis 鈥� eczema.

The School of Medicine Basic Sciences Dean鈥檚 Lecture featured renowned immunologist, virologist, and alumnus聽Dr. Barney S. Graham. In his talk, 鈥淩eflections on Pandemics and the Future of Medicine,鈥� Graham discussed his early research experiences leading up to his聽seminal work on the first experimental COVID-19 vaccines, along with his observations on the pandemic and hopes for the future of medicine.

A Vanderbilt study finds that Moderna鈥檚 COVID-19 vaccine is safe and effective in children 6 months to 5 years of age.

A team at Case Western Reserve University and Vanderbilt University Medical Center has determined with atomic-level precision how two established drugs bind to and alter the conformation of a cell membrane transporter protein called NKCC1, shutting down its activity.

Researchers at Vanderbilt University Medical Center have found that the change in a single letter of the genetic code promotes, in a mouse model, the development of inflammation, high blood pressure and resulting kidney damage.

Vanderbilt reseach shows that resources for lung cancer screening programs increased the number of veterans screened.

Vanderbilt researchers are studying precancerous lesions and early cancers in the colon, with the goal of developing new ways to prevent colorectal cancer, the nation鈥檚 second leading cancer killer.

Assistant Professor of Biochemistry聽Emily Hodges聽and graduate student聽Tyler Hansen聽used a blended approach to create a new, multi-omic method to identify and characterize gene regulatory elements鈥攏on-coding DNA sequences that control gene expression鈥攊n the human genome.

A grant from the National Institutes of Health will allow John T. Wilson to explore ways to use recently developed nanoparticles to stimulate immunity pathways in children, with the aim of making immunotherapy treatments for neuroblastoma more effective.

A new model suggests that a protein involved in the generation of high-density lipoprotein (HDL) works differently than previously thought.

Vanderbilt researcher Nilanjan Sarkar is partnering with Lorraine Mion of the Ohio State University and two Middle Tennessee long-term care facilities to investigate how augmented reality technologies can ease loneliness among residents.

When high blood pressure was induced in young mice, they had bone loss and osteoporosis-related bone damage comparable to older mice, according to new research presented at the American Heart Association鈥檚 Hypertension Scientific Sessions 2022 conference.

New Vanderbilt research could inform therapeutic strategies for enhancing thymic function when desired 鈥� such as during aging, recovery from radiation therapy or chemotherapy, or other conditions that reduce T cell output.

Gastrointestinal inflammation, such as occurs in inflammatory bowel disease, triggers the expansion of a population of 鈥渂one-eating鈥� cells, leading to bone loss.

Researchers at Vanderbilt University Medical Center have discovered why the uropathogenic bacterium E. coli, the leading cause of urinary tract infections, is so tenacious; their findings could lead to new ways to prevent recurrent UTIs.

Vanderbilt researchers have developed an active machine learning approach to predict the effects of tumor variants of unknown significance, or VUS, on sensitivity to chemotherapy. Characterizing VUS can maximize clinical care and precision medicine for each patient. Read More

The American Academy of Nursing has selected four Vanderbilt School of Nursing faculty for its 2022 cohort of fellows.

A proposal to enhance wellness and resiliency training, led by RC Stabile, associate director for trainee wellbeing in the Office of Biomedical Research Education and Training, was recently awarded by the National Institute of General Medical Sciences.

Assistant Professor Megan Simmons has been named academic director for the Psychiatric-Mental Health Nurse Practitioner Specialty at the Vanderbilt University School of Nursing, effective August 1.聽